850105P

20:4 Lyso PI

1-arachidonoyl-2-hydroxy-sn-glycero-3-phosphoinositol (ammonium salt), powder

• Synonym(e): 1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-2-hydroxy-sn-glycero-3-phospho-(1′-myo-inositol); PI(20:4(5Z,8Z,11Z,14Z)/0:0)
• Empirische Formel (Hill-System): C₂₉H₅₂NO₁₂P
• CAS-Nummer: 1246430-04-5
• Molekulargewicht: 637.70
• UNSPSC-Code: 51191904
• NACRES: NA.25

Eigenschaften

• Assay: >99% (LPI; may contain up to 10% of the 2-LPI isomer, TLC)
• Form: powder
• Verpackung: pkg of 1 × 100 μg (with stopper and crimp cap (850105P-100ug)); pkg of 1 × 500 μg (with stopper and crimp cap (850105P-500ug))
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand 850105P
• Lipid-Typ: phospholipids
• Versandbedingung: dry ice
• Lagertemp.: −20°C
• SMILES String: [H][C@@](COP([O-])(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O)=O)(O)COC(CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)=O.[NH4+]

Beschreibung

Allgemeine Beschreibung

20:4 Lyso PI or 1-arachidonoyl-2-hydroxy-sn-glycero-3-phosphoinositol (ammonium salt) is an ammonium salt of phosphoinositol, with substitution of arachidonic acid at the sn-1 position of the glycerol backbone.

Increased circulating levels of L-alpha-lysophosphatidylinositol (LPI) are associated with cancer and LPI is a potent ligand for the G-protein-coupled receptor GPR55.

Anwendung

20:4 Lyso PI or has been used as a lipid standard for optimization of the liquid chromatography mass spectrometry (LC-MS) method conditions.

Verpackung

2 mL Amber Serum Vial with Stopper and Crimp Cap (850105P-100ug)

2 mL Amber Serum Vial with Stopper and Crimp Cap (850105P-500ug)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): No data available
• Flammpunkt (°C): No data available